Fingerprint
Dive into the research topics of 'Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically